|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/337 | |
| A61K 31/513 | |||
| A61K 31/704 | |||
| A61K 38/03 | |||
| A61K 38/10 | |||
| A61K 38/16 | |||
| A61K 38/20 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61K 31/675 | |||
| A61K 33/24 | |||
| A61K 38/22 | |||
| A61K 38/21 | |||
| A61K 38/17 |
| (11) | Number of the document | 2144607 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08733184.9 |
| Date of filing the European patent application | 2008-04-10 | |
| (97) | Date of publication of the European application | 2010-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2014-01-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/059949 |
| Date | 2008-04-10 |
| (87) | Number | WO 2008/127996 |
| Date | 2008-10-23 |
| (30) | Number | Date | Country code |
| 911773 P | 2007-04-13 | US |
| (72) |
GULATI, Anil, US
GURU, Reddy, US
LENAZ, Luigi, US
|
| (73) |
Spectrum Pharmaceuticals, Inc.,
157 Technology Drive, Irvine, CA 92618,
US
The Board Of Trustees Of The University Of Illinois, 352 Henry Administration Building 506 South Wright Street, Urbana, IL 68101, US |
| (54) | COMPOSITIONS FOR CONTRIBUTING TO THE TREATMENT OF CANCERS |
| COMPOSITIONS FOR CONTRIBUTING TO THE TREATMENT OF CANCERS |